Search
Home
Business
Tech
Education
Interviews and Features
Others
Books
CSR
Environment
Entertainment
Health and Wellness
Finance
Hospitality
International
Lifestyle
Sports
Startup
Travel
Webnewswire
Leading newswire service
Home
Business
Tech
Education
Interviews and Features
Others
Books
CSR
Environment
Entertainment
Health and Wellness
Finance
Hospitality
International
Lifestyle
Sports
Startup
Travel
Home
Tags
Everest
Tag: Everest
Business
Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib
Correspondent
-
July 9, 2026
0
Business
Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China
Correspondent
-
June 27, 2026
0
Business
Everest Medicines and Hainan Herui have actually participated in a commercialization partnership connecting to Hainan Herui’s budesonide enteric pills, even more improving client access to the medication
Editor
-
June 24, 2026
0
Business
Everest Medicines Enters into Exclusive Licensing Agreement with Dimerix for DMX-200 in Greater China, South Korea and Southeast Asia
Leslie Atkins
-
June 17, 2026
0
Business
Everest Medicines Secures Exclusive License for Sumecigrel in Asia-Pacific, Expanding Its Cardiovascular Product Portfolio
Leslie Atkins
-
June 10, 2026
0
Business
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China, Strengthen Presence in Ophthalmology
Leslie Atkins
-
June 9, 2026
0
Business
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market
Editor
-
June 7, 2026
0
Business
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion
Editor
-
June 5, 2026
0
Business
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
Editor
-
May 23, 2026
0
Business
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
Editor
-
October 31, 2025
0
Business
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
Leslie Atkins
-
October 14, 2025
0
Business
Everest Medicines Announces 2025 Interim Results: ‘Dual-Engine’ Strategy Driving Strong Synergies Between Commercialization and R&D
Editor
-
September 4, 2025
0
Business
Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Leslie Atkins
-
August 14, 2025
0
Business
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
Correspondent
-
August 8, 2025
0
Business
Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies
Editor
-
August 4, 2025
0
Business
Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation
Editor
-
July 5, 2025
0
Business
Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area
Editor
-
December 19, 2024
0
Business
Everest Medicines Announces NEFECON(R)’s Full Approval in South Korea
Correspondent
-
November 20, 2024
0
Business
Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy
Editor
-
October 21, 2024
0
Business
Everest Medicines’ Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery
Editor
-
October 21, 2024
0
Business
The Everest Foundation Brings Joy To Loving Hands Children’s Home
-
February 25, 2022
0
